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Abstract
Background: Although liquid-based cytology (LBC) is now recommended for cervical cancer
screening, it requires expensive automated devices and materials. To evaluate the efficiency of
inexpensive LBC methods relying on an inexpensive fixative liquid, Easyfix®, we compared the
results obtained by the liquid-based cytology (LBC) diagnoses performed by cytocentrifugations
(Papspin® and Turbitec®) with those obtained by histology. Furthermore, we evaluated the
efficiency of the fixative liquid, Easyfix®, to preserve HPV DNA in the collected samples.
Method: 266 LBC were compared with 174 colposcopies and 91 Loop Electrosurgical Excision
Procedure (LEEP). Among the LBC, 51 were performed using the Papspin® system and 215 were
performed using the Turbitec® system. To control the quality of the preservation liquid, Easyfix®,
we correlated the results of HCII assays with those of HPV PCR.
Results: For Papspin® and Turbitec® systems, the sensitivities were respectively 82.6% (95% CI:
61.2–95.0%, p < 0.001) and 75.0% (95% CI: 64.4–89.8%, p < 0.001) and the specificities were 92.6%
(95%CI: 76.5–99.1%, p < 0.001) and 96.2% (95% CI: 91.3–98.7%, p < 0.001). We find no statistical
difference between the results of the both systems (p = ns). The sensitivity of the HCII was 86.4%
(95% IC: 77.4–92.8%, p < 0.001) and the specificity was 39.4% (95% CI: 31.2–48.1%, p < 0.001). The
comparison between HCII and HPV-PCR shows a good correlation: the kappa was 0.89.
Conclusion: LBC performed by cytocentrifugations are inexpensive, reduce inadequate smears,
show excellent efficiency and allow HPV detection by molecular biology.
Background
For more than ten years, liquid-based cytology (LBC) has
been developed for cervical cancer screening. Unlike to
Conventional cervical Smears (CS), cells are scattered in a
fixative liquid to produce a thin layer of cells on slides.
The main advantages of this technique are to reduce the
number of inadequate smears and to provide enough cells
for the detection of infectious agents such as human pap-
illomavirus (HPV) through molecular biology techniques
[1-3]. At the moment, the majority of these techniques are
using expensive automated devices leading to a significant
increase in the price of LBC [4,5].
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The LBC performed by cytocentrifugations exist since the
1970s and have been developed for the automated read-
ing of cervical cancer cytology. Preliminary studies show
that they significantly reduce the cost of LBC [6-13]. In
Central Europe, the LBC performed by cytocentrifugation
consist mainly in the Papspin® system (ThermoShandon
Inc, Pittsburgh, the USA), in the CytoSCREEN® system
(Seroa, Monaco, Monaco) and in the Turbitec® system
(Labonord, Templemars, France). These last two tech-
niques use the Hettich cytocentrifuge (Andreas Hettich
Corp, Tuttligen, Germany).
The first purpose of this study was to evaluate the per-
formance of two LBC performed by centrifugations: the
Papsin® and the Turbitec® systems. In addition, we evalu-
ated the efficiency of the fixative liquid, Easyfix®
(Labonord, Templemars, France) to preserve HPV DNA.
Materials and methods
Patients
A total of 268 LBC were collected from 177 women (mean
of age: 37.3 +/-10.8 years) from January 2002 to Decem-
ber 2004 in a routine gynecologic setting at the Depart-
ment of Gynecology (CHU de Charleroi, Belgium).
Indications for gynecological consultation were based on
previous abnormal conventional cervical smears in a pop-
ulation-based screening. According to the histological
diagnosis, the age groups were quite homogeneous,
except for the women in the CIN3 group who were
slightly younger than those of the other groups (Table 1,
p = 0.04).
174 colposcopies associated with biopsy (30 for Papspin®
and 144 for Turbitec®) and 92 Loop Electrosurgical Exci-
sion Procedure (LEEP) (21 for Papspin® and 71 for Tur-
bitec®) were correlated with all LBC. All the cells were
collected using a Cervexbrush® (Rovers, Oss, Nederlands),
immersed in 15 ml of a non-buffered alcoholic fixative
liquid containing 30% ethanol (Easyfix®, Labonord Corp,
Templemars, France). 2 LBC corresponding to a cytologi-
cal and histological diagnosis of cervical adenocarcinoma
were discarded. All the patients were informed of the pur-
pose of this study and agreed voluntarily to take part in it.
Methods
The Easyfix® cell fixative solutions, containing the Cervex-
brush® and the cells, were homogenized by mechanical
agitation (Vortex®) for at least 30 seconds.
For the Turbitec® technique, 4 drops albumin (StickOn®,
Labonord) were put on a polylysined slide placed in the
centrifuge chamber (Hettich Centrifuge®). The centrifuge
chambers had a final volume of 6 ml; the surface of cells
projection on the slide was 240 mm2. The cellularity was
estimated using a photoelectric cell analyzer (Labonord)
according to the dilution of the Easyfix® sample: 200 µl,
500 µl, 1 ml, 3 ml or 5 ml of Easyfix® solution. This vol-
ume was placed in the centrifuge chamber and diluted
with an alcoholic fixative liquid containing polyethylene
glycol (Cytofix®, Labonord), in order to obtain a finale
volume of 6 ml. After 10 minutes centrifugation at 2000
revolutions per minute (rpm), the liquid was discarded.
The Papspin® technique was performed as described previ-
ously in the literature with the exception of the use of the
Easyfix® and the Cytofix® fixative liquids [14]. The surface
of cells projection was 300 mm2. The volume of dilution
was respectively 500 µl, 1 ml and 2 ml and the finale vol-
ume was 3 ml, according to the turbidity of the sample.
The chambers (Megafunnel®  – ThermoShandon) were
centrifuged 5 minutes at 1250 rpm (CytoSpin® – Ther-
moShandon) [9-12].
For cytology diagnosis, we used the Bethesda system
2001: within the normal limits (WNL), atypical squa-
mous cells cannot exclude high grade squamous intraepi-
thelial lesion (ASC-H), atypical squamous cells of
undetermined significance (ASC-US), low and high grade
squamous intraepithelial lesions (Lg-SIL and Hg-SIL)
[14]. The histology diagnoses were classified in 4 groups:
WNL, Cervical Intraepithelial Neoplasia grade 1 (CIN 1),
grade 2 (CIN 2) and grade 3 (CIN3). For the cytology
diagnosis and the HCII results, the reference standard was
the CIN2 and above (CIN2+). No cytology or histology
diagnoses were revised.
Table 1: Patients age distribution and samples distribution among the Papspin® and Turbitec® LBC according to the histological 
diagnosis.
Histology diagnosis Papspin® Age (Years)* Turbitec® Age (Years)*
WNL 12/51 (23.5 %) 45.1 +/- 15.6 86/215 (39.9%) 38.3 +/- 11.9
CIN 1 16/51 (31.3%) 42.6 +/- 8.9 46/215 (21.1%) 37.3 +/- 11,6
CIN 2 4/51 (7.8%) 38.6 +/- 2.8 15/215 (6.9%) 39.6 +/- 13.2
CIN 3 19/51 (37.2%) 33.5 +/- 7.9 70/215 (32.2%) 34.3 +/- 7.8CytoJournal 2005, 2:15 http://www.cytojournal.com/content/2/1/15
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225 HPV tests performed by the Hybrid Capture II® (Digene
Corp, Beltsville/HCII) were also realized (38 for Papspin®
and 187 for Turbitec®). The HCII assays were performed
on 5 ml of the residual liquid-based samples. After 5 min.
centrifugation at 2000 rpm, the supernatant was dis-
carded. The cellular pellet was washed once with 1 ml
PBS, resuspended in 100 µl of Cervical Sample ® (Digene
Corp, Beltsville) and denatured in an alkaline solution.
Classical hybridization, detection and calibration were
made according to the HCII kit's instructions [15,16]. We
only used the probes against the high-risk HPV: 16, 18,
31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68. The HCII
results were expressed as positive or as negative depending
on the relative light unit of 1 pg/ml of HPV DNA.
We also performed PCR techniques to detect HPV DNA in
72 samples fixed in Easyfix® solutions for 3.2 +/- 0.9
months. Total cellular DNA were extracted by a freeze/
defreeze method as previously described [17] or were
purified using the QIAamp blood minikit (Qiagen). The
quality of the extracted DNA was evaluated by PCR using
beta-globin specific primers, as described [18]. HPV-spe-
cific PCR were performed using the general primers, as
previously described [19].
Statistics
A Chi 2 or a Fisher exact, ANOVA and kappa of Cohen tests
were performed. A p-value less than 0.05 was considered
statistically significant. The results are expressed as a mean
+/- standard deviation or as a percentage.
We use the Epi Info 2002 revised 2003 (Centers of Disease
Control and Prevention – W.H.O, Atlanta, USA) and the
Analyse-it®  1.7 (Analyse-it Software, Leeds, England)
programs.
Results
The microscopic reading of the LBC, performed by cyto-
centrifugations, was virtually the same as for other classi-
cal LBC techniques, especially the Prepstain®  system,
although a higher background (cell debris, inflammatory
cells, lactobacillus, blood...) was observed but did not
influenced the lecture (figures 1 to 4).
According to Bethesda 2001, only 2 smears (0.9%) were
classified as inadequate for cytology interpretation
because of too low cellularity. These two smears were per-
formed by Turbitec®. Indicative minor quality criteria were
absence of cells junction for 11/51 Papspin® (21.5%) vs
24/215 for Turbitec® (11.1%), low cellularity for 1/51
(1.9%) vs 4/215 (1.8%), hemorrhage for 2/51 (3.8%) vs
6/215 (2.7%), severe inflammation for 1/51 (1.9%) vs 1/
215 (0.4%) and severe cytolysis for 2/51 (3.8%) vs 2/215
(0.9%) of LBC. However, we can not draw any statistical
conclusion because of the too low number of LBC.
In order to evaluate the performance of the LBC per-
formed by cytocentrifugations from ours clinical samples
Lg-SIL : cellularity is satisfactory (Papanicolaou stain, high  magnification – 20x objective, Papspin® system) Figure 1
Lg-SIL : cellularity is satisfactory (Papanicolaou stain, high 
magnification – 20x objective, Papspin® system). HCII was 
positive.
Same case a high magnification : see cytoplasmic and nuclear  details (Papanicolaou stain, high magnification – 100x objec- tive, Papspin® system) Figure 2
Same case a high magnification : see cytoplasmic and nuclear 
details (Papanicolaou stain, high magnification – 100x objec-
tive, Papspin® system).CytoJournal 2005, 2:15 http://www.cytojournal.com/content/2/1/15
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preserved in the Easyfix® liquid, we compared the results
of 2 methods of LBC centrifugations with the histological
diagnosis.
According to the histology diagnosis, the samples were
homogeneously distributed between the Turbitec® and the
Papspin® cytocentrifugation systems (Table 1). There was
a slight significant difference between the distribution of
the histology diagnosis of the Turbitec® and Papspin® sys-
tems only for the group of the WNL (Table 1, p = 0,02).
The comparison between the results obtained by the two
cytocentrifugation LBC and those obtained by histology is
shown in Table 2. There was no statistical difference with
caution of the small number of Papspin® sample. The glo-
bal tendency was very similar except for ASC-H which are
more frequently cited for Turbitec® (1/51 or 1.9% vs 13/
215 or 6.0%, p = ns). This is probably due to the fact that
Papspin® LBC were performed after Turbitec® LBC when
ours cytologists and pathologists were more used to the
Bethesda system 2001.
38 samples from the Papspin® and 187 from the Turbitec®
methods were also analyzed in the HCII assay. The fre-
quency of HPV performed by HCII was respectively for
Papspin®  and Turbitec®  of 50.0% vs 30.0% for WNL,
60.0% and 51.8% for ASC-US, 100% vs 100% for ASC-H,
87.5% vs 71.4% for Lg-SIL and 100% vs 85.0% for Hg-SIL.
Those results suggested that HPV DNA was more detected
among the ASC-US than among the WNL and that the
HPV DNA is more frequently detected for ASC-H, Lg-SIL
and Hg-SIL. However, because of the small cases in each
group, no conclusion can be made.
The sensitivity and the specificity of Papspin® and Tur-
bitec® methods were calculated using the CIN2+ histology
detection as the reference standard for the cytological
diagnosis of Hg-SIL. Respectively for Papspin® and Tur-
bitec®, the sensitivity was 82.6% (95%CI: 61.2–95.0%, p
< 0.001) and 75.0% (95% CI: 64.4–89.8%, p < 0.001)
and the specificity was 92.6% (95%CI: 76.5–99.1%, p <
0.001) and 96.2% (95%CI: 91.3–97.7%, p < 0.001).
There was no statistical difference between the 2 LBC sys-
tems (p = ns).
The false negatives LBC (with CIN2+ as reference stand-
ard) consist of 4 Papspin®, all Lg-SIL and all positive for
HPV/HCII (4/4) and of 22 Turbitec®, 11 Lg-SIL (8/11 pos-
itive for HCII), 5 ASC-US (4/5 positive for HCII) and 6
ASC-H (6/6 positive for HCII). The false positives LBC
consist of 2 for Papspin® and 4 for Turbitec®, all positive
for HCII (2/2 and 4/4) and all with a colposcopy with
only one small biopsy which is no representative of the
whole cervix.
We also evaluated the quality of the Easyfix® fixative liquid
to preserve HPV DNA in the residual materials of 72 LBC
performed by cytocentrifugations. Even after 3.2+/-0.9
months, at room temperature, beta-globin or HPV DNA
Hg-SIL : presence of inflammatory cells which did not influ- enced the lecture (Papanicolaou stain, high magnification –  20x objective, Turbitec® system) Figure 3
Hg-SIL : presence of inflammatory cells which did not influ-
enced the lecture (Papanicolaou stain, high magnification – 
20x objective, Turbitec® system). HCII was positive.
Same picture a high magnification : see cytoplasmic and  nuclear details (Papanicolaou stain, high magnification – 40x  objective, Turbitec® system) Figure 4
Same picture a high magnification : see cytoplasmic and 
nuclear details (Papanicolaou stain, high magnification – 40x 
objective, Turbitec® system).CytoJournal 2005, 2:15 http://www.cytojournal.com/content/2/1/15
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could still be amplified by PCR in those samples. The
comparison between HPV detection using either general
primer PCR or HCII tests showed a Kappa test of 0.89 (p
< 0.001). Three cases were positive for the HPV PCR and
negative for the HCII and one case was negative for the
HPV PCR and positive for the HCII. This last case was also
negative for the beta-globin PCR explaining that HPV
could not be detected because of the poor quality of the
extracted cellular DNA. The stability of DNA in the
Easyfix® medium after 3 months was in general excellent.
Discussion
In this study, we demonstrated the feasibility and the effi-
ciency of inexpensive LBC performed by cytocentrifuga-
tions: the Papspin® and the Turbitec® systems. We use
colposcopy with biopsy or LEEP as reference standard.
The diagnosis threshold was set up to the high-grade cer-
vical intraepithelial neoplasia (CIN2+). This could have
led to a selection bias of a high-risk patient population.
Therefore, ours results are only acceptable in the frame-
work of diagnosis but must be interpreted with some cau-
tion in the framework of cervical cancer screening in
which the number of healthy patients should usually be as
high as possible.
The adequacy of the LBC has been already described in the
literature: Weynand et al. (2003) [12] described 0.7% of
inadequate samples with the Papspin®  system and
Bergeron et al. (2003) [13] found 0.14% with the Cyto-
Screen system (which are technically very similar of the
Turbitec® system). These authors also demonstrated the
superiority of the quality of LBC in comparison with those
of CS. With cautions of small number of our samples and
using the norms of the Bethesda system 2001, we also
found only 0.9% of inadequate cytology [20-24]. Chhieng
et al. (2004) also described a similar rate of 0.81% of
unsatisfactory sample following the implementation of
Bethesda 2001 [20]. Within a comparative study of Thin-
prep®, Autocyte PREP® and the new manual LBC of Digene
(DNACITOLIQ®, Digene), Alves et al. (2004) also con-
cluded that in spite of the different methodologies, the 3
methods adequately preserved cellular structure for mor-
phologic evaluation [21]. Nam et al. (2004) comparing
Thinprep® and a manual LBC, called MonoPrep2®, drew
similar conclusions [22] All of these authors concluded
that manual LBC are cost-effective and provide an alterna-
tive method to the currently automated technique of LBC.
Nevertheless, rare are the studies describing the accuracy,
in terms of sensibility and specificity, of these manual LBC
and particularly for cytocentifugation methods. In our
study, to detect the CIN2+, the efficiency of ours LBC, per-
formed by cytocentrifugations, Papspin® and Turbitec®,
are quite similar. Indeed, their sensitivity are respectively
82.6 % and 75% (p = ns) and their specificity are respec-
tively 92.6 % and 96.2% (P = ns). The small number of
Papspin® LBC in our study is due to the subsequent choice
for the Turbitec® method which is more cost-effective. By
comparison with published results our LBC efficiency per-
formed by cytocentrifugation seems better than CS. A sen-
sitivity of 68% and the specificity of 79% has been indeed
reported for the CS and similarly a sensitivity of 76% and
a specificity of 86% was reported by others for the Thin-
prep® [23-26]. Recently, a sensitivity and a specificity quite
similar to ours was also reported for the manual LBC of
Digene, respectively 75.3% and 86.4% [27].
One main advantage of LBC is that they allow ancillary
techniques such as those used in immunocytochemistry
or molecular biology [28-32].
The Easyfix® fixative fluid, used in this study for both LBC,
is not yet accredited for the use of HCII. With a Kappa test
of 0.89 between DNA/HPV PCR and HCII, and with the
comparison with the cytological or histological diagnosis,
we can conclude that this liquid is efficient for molecular
Table 2: Comparison of cytological and histological diagnosis of Papspin® and Turbitec®.
Histological diagnosis Cytological Diagnosis Papspin®
WNL ASC-US ASC-H Lg-SIL Hg-SIL
WNL 5/6 (83.3%) 2/5 (40.0%) - 4/18 (27.8%) -
CIN 1 1/6 (16.7%) 3/5 (60.0%) 1/1 (100%) 9/18 (50.0%) 2/21 (9.5%)
CIN 2 - - - 2/18 (5.5%) 3/21 (14.3%)
CIN 3 - - - 3/18 (16.7%) 16/21 (76.2%)
Turbitec®
WNL 37/42 (88.1%) 17/29 (58.6%) 6/13 (46.1%) 22/63 (34.9%) 2/68 (2.9%)
CIN 1 5/42 (11.9%) 7/29 (24.1%) 1/13 (7.8%) 30/63 (47.6%) 3/68 (4.4%)
CIN 2 - - - 2/63 (3.3%) 13/68 (19.1%)
CIN 3 - 5/29 (17.3%) 6/13 (46.1%) 9/63 (14.3%) 50/68 (73.6%)CytoJournal 2005, 2:15 http://www.cytojournal.com/content/2/1/15
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biology and for the HCII technique. Similar conclusions
have recently been reached by Leduc et al.(2004) who
compared 250 cervical samples which have been fixated
with both Easyfix® and Cervical Sampler liquid® (Digene
Corp). They found a Kappa of 0.74 [15]. In our study, the
sensitivity of HCII, compared with CIN2+, is 86.4 % and
the specificity is 39.4 %. These results are similar to those
found by Lee et al. (2004) who used Cervical Sampler liq-
uid® (Digene) and found a sensitivity of 94.2% and a spe-
cificity of 52.4%[33]. Howard et al. (2002) had similar
results with a 81.8% sensitivity and a 51.5% specificity
[34]. In our study, the slight difference of specificities is
likely been due to the patients selection with high risk
HPV infection. Indeed, 50% (41/81) of these HCII false
positives showed a CIN1 at the biopsy. Among the others
without histological lesion, only 7/40 had no cytological
lesion (WNL).
Actually, it is generally accepted that the HCII test is more
sensitive and less specific than cytology to identify Hg or
Lg-SIL. However, in the case of ASC-US, a combination of
HPV DNA and Papanicolaou smears can certainly increase
the sensibility of the cervical cancer screening [35-39].
Likely, a cost-effective LBC associated of HPV DNA will
probably have a place to reduce cervical cancer in under-
developed countries or small laboratories which cannot
invest expensive equipment.
We demonstrated by this study that LBC performed by
cytocentrifugation are efficient and also allow the HPV
DNA preservation in the Easyfix® as no-buffered alcoholic
fixative liquid.
Inexpensive LBC performed by cytocentrifugations can be
performed by small laboratories which cannot invest in
expensive automated equipments.
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